MicroRNA as Biomarkers of Malignant Mesothelioma

C. D. Hoang, Robert A Kratzke

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Malignant pleural mesothelioma is a disease with poor prognosis and no cure. Worldwide, the incidence of this cancer problem continues to rise. The biology and tumorigenesis of this complex mesenchymal-type tumor remains incompletely understood. Over the past decade, emerging evidence has demonstrated that microRNAs, small nonprotein coding single-strand RNA negatively regulating gene expression, are deranged and exert significant biologic effects in multiple malignancies. This review will provide an update of the current state of microRNA translational research aimed at unraveling the novel biomarkers pertinent in several clinical problems of mesothelioma.

Original languageEnglish (US)
Title of host publicationTranslating MicroRNAs to the Clinic
PublisherElsevier Inc.
Pages203-221
Number of pages19
ISBN (Print)9780128005538
DOIs
StatePublished - Sep 29 2016

Fingerprint

Biomarkers
MicroRNAs
Gene expression
Tumors
Neoplasms
Translational Medical Research
Mesothelioma
RNA
Carcinogenesis
Gene Expression
Incidence
Malignant Mesothelioma

Keywords

  • Asbestos
  • Biomarker
  • Biphasic
  • Epithelioid
  • Gene
  • Interactome
  • Mesothelioma
  • Microarray
  • MicroRNA
  • Sarcomatoid

Cite this

Hoang, C. D., & Kratzke, R. A. (2016). MicroRNA as Biomarkers of Malignant Mesothelioma. In Translating MicroRNAs to the Clinic (pp. 203-221). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800553-8.00008-1

MicroRNA as Biomarkers of Malignant Mesothelioma. / Hoang, C. D.; Kratzke, Robert A.

Translating MicroRNAs to the Clinic. Elsevier Inc., 2016. p. 203-221.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hoang, CD & Kratzke, RA 2016, MicroRNA as Biomarkers of Malignant Mesothelioma. in Translating MicroRNAs to the Clinic. Elsevier Inc., pp. 203-221. https://doi.org/10.1016/B978-0-12-800553-8.00008-1
Hoang CD, Kratzke RA. MicroRNA as Biomarkers of Malignant Mesothelioma. In Translating MicroRNAs to the Clinic. Elsevier Inc. 2016. p. 203-221 https://doi.org/10.1016/B978-0-12-800553-8.00008-1
Hoang, C. D. ; Kratzke, Robert A. / MicroRNA as Biomarkers of Malignant Mesothelioma. Translating MicroRNAs to the Clinic. Elsevier Inc., 2016. pp. 203-221
@inbook{5112eec6ec184fe28d2389c7727a80d4,
title = "MicroRNA as Biomarkers of Malignant Mesothelioma",
abstract = "Malignant pleural mesothelioma is a disease with poor prognosis and no cure. Worldwide, the incidence of this cancer problem continues to rise. The biology and tumorigenesis of this complex mesenchymal-type tumor remains incompletely understood. Over the past decade, emerging evidence has demonstrated that microRNAs, small nonprotein coding single-strand RNA negatively regulating gene expression, are deranged and exert significant biologic effects in multiple malignancies. This review will provide an update of the current state of microRNA translational research aimed at unraveling the novel biomarkers pertinent in several clinical problems of mesothelioma.",
keywords = "Asbestos, Biomarker, Biphasic, Epithelioid, Gene, Interactome, Mesothelioma, Microarray, MicroRNA, Sarcomatoid",
author = "Hoang, {C. D.} and Kratzke, {Robert A}",
year = "2016",
month = "9",
day = "29",
doi = "10.1016/B978-0-12-800553-8.00008-1",
language = "English (US)",
isbn = "9780128005538",
pages = "203--221",
booktitle = "Translating MicroRNAs to the Clinic",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - MicroRNA as Biomarkers of Malignant Mesothelioma

AU - Hoang, C. D.

AU - Kratzke, Robert A

PY - 2016/9/29

Y1 - 2016/9/29

N2 - Malignant pleural mesothelioma is a disease with poor prognosis and no cure. Worldwide, the incidence of this cancer problem continues to rise. The biology and tumorigenesis of this complex mesenchymal-type tumor remains incompletely understood. Over the past decade, emerging evidence has demonstrated that microRNAs, small nonprotein coding single-strand RNA negatively regulating gene expression, are deranged and exert significant biologic effects in multiple malignancies. This review will provide an update of the current state of microRNA translational research aimed at unraveling the novel biomarkers pertinent in several clinical problems of mesothelioma.

AB - Malignant pleural mesothelioma is a disease with poor prognosis and no cure. Worldwide, the incidence of this cancer problem continues to rise. The biology and tumorigenesis of this complex mesenchymal-type tumor remains incompletely understood. Over the past decade, emerging evidence has demonstrated that microRNAs, small nonprotein coding single-strand RNA negatively regulating gene expression, are deranged and exert significant biologic effects in multiple malignancies. This review will provide an update of the current state of microRNA translational research aimed at unraveling the novel biomarkers pertinent in several clinical problems of mesothelioma.

KW - Asbestos

KW - Biomarker

KW - Biphasic

KW - Epithelioid

KW - Gene

KW - Interactome

KW - Mesothelioma

KW - Microarray

KW - MicroRNA

KW - Sarcomatoid

UR - http://www.scopus.com/inward/record.url?scp=85010005920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010005920&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800553-8.00008-1

DO - 10.1016/B978-0-12-800553-8.00008-1

M3 - Chapter

SN - 9780128005538

SP - 203

EP - 221

BT - Translating MicroRNAs to the Clinic

PB - Elsevier Inc.

ER -